Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined